A recent study found the combination of inulin and an arabinoxylan extract, marketed as Naxus by BioActor, helped reduce the intake of calories in ad libitum meals.
A recent study1 found the combination of inulin and an arabinoxylan extract marketed as Naxus by BioActor (Maastricht, Netherlands), helped reduce the intake of calories in ad libitum meals. In the study, 20 healthy men were given either 8 grams per day of the inulin and arabinoxylan mixture or weight-matched maltodextrin control for 21 days. Each participant took both the intervention and control for 21 days, with a 14-day washout period in between.
The primary outcome researchers wanted to measure was the impact this combination had on perceive satiety and appetite. The secondary outcomes were the energy intake of an ad libitum meal, fecal short-chain fatty acid (SCFA) concentration and fecal microbiota composition.
While the intervention did not have any effect on perceived satiety and appetite, the combination of inulin and arabinoxylan extract was associated with a reduction in energy intake in an ad libitum meal, as well as an increase in SCFA concentration and increase in the cell counts of microbial genera, including Bifidobacteria and Lactobacilli.
According to a press release from BioActor, it is not uncommon to see a difference between self-reported appetite and actual calorie intake. The measure of actual food intake is therefore a more objective measure. This means, that while the subjects did not report an increase in satiety or decrease in hunger, the subjects consuming inulin and arabinoxylan did in fact eat less. The elevation of the SCFA acetate, which has the ability to independently influence appetite, may be one explanation for why the subjects ate fewer calories, according to the researchers.
Further research is necessary to understand the ingredient’s mechanism of action and how it might be useful for weight management.
Reference
Collins, S.M.; Gibson, G.R.; Stainton, G.N.; Bertocco, A.; Kennedy, O.B.; Walton, G.E.; Commane, D.M. Chronic Consumption of a Blend of Inulin and Arabinoxylan Reduces Energy Intake in an Ad Libitum Meal but Does Not Influence Perceptions of Appetite and Satiety: A Randomised Control-Controlled Crossover Trial. Eur J Nutr. 2023, 62(5): 2205-2215, DOI: 10.1007/s00394-023-03136-6
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
Standardized valerian extract shows acute sleep benefits after one day, says recent study
December 10th 2024Results showed that after a single dose, people taking the Valerian extract experiences an acute benefit on sleep, namely a significant increase in actual sleep time compared to baseline.